- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Financial Crisis: A High Price to Pay for New Treatment Options
Peter Salgo, MD, and Bryan Loy, MD, examine the financial impact of new treatment options in medical oncology. Dr Salgo notes that due to cost sharing, premiums and deductibles continue to increase, and treatment costs place a heavy burden on patients.
Dr Loy remarks that the nation is already in a financial crisis, and discusses why price sensitivity discussions need to occur sooner rather than later. He explains that while policy changes can assist in the introductory stages of new innovations and in the design of future clinical trials, there are instances when patients do not have the financial resources available to fund the treatment recommended for them. Also, patients who are insured may experience financial difficulties related to deductible requirements or out-of-pocket expenses that force them to consider discontinuing treatment.
Discussions on how to handle the financial burden of a catastrophic illness should not take place only when patients have exhausted their resources, but rather as early as possible, adds Dr Loy.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More
